+ND Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Serotinyserotiny.bioin𝕏Seed · Jul 2018 · $3M
Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Justin Farlow(Co-founder)inColin Farlow(Co-founder)Eric Moessinger(Director)in
Co-investors8VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.